| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/06/2011 | EP2303332A2 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds |
| 04/06/2011 | EP2303328A1 Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy |
| 04/06/2011 | EP2303326A2 Treatment of solid tumors with tissue inhibitors of metalloproteinases (timps) |
| 04/06/2011 | EP2303319A2 Compositions, methods and kits for eliciting an immune response |
| 04/06/2011 | EP2303307A2 Recombinant preparation of bromelain inhibitors and bromelain inhibitor precursor |
| 04/06/2011 | EP2303286A2 Compositions for inducing immune responses specific to globo h and ssea3 and uses thereof in cancer treatment |
| 04/06/2011 | EP2303282A2 Treatment using continuous low dose application of sugar analogs |
| 04/06/2011 | EP2303281A1 Transdermal pharmaceutical compositions comprising danazol |
| 04/06/2011 | EP2303280A2 Compositions and methods for treatment of inflammation and hyperkeratotic lesions |
| 04/06/2011 | EP2303277A1 Inhibitors of akt activity |
| 04/06/2011 | EP2303276A1 Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl]oxy}quinazoline |
| 04/06/2011 | EP2303275A2 Smoothened receptor modulators |
| 04/06/2011 | EP2303274A1 Multiple myeloma treatments |
| 04/06/2011 | EP2303273A1 Medical intervention in haematological cancers |
| 04/06/2011 | EP2303255A1 Pharmaceutical compositions useful for the treatment of cancers, in particular acute myeloid leukemia and acute promyelocytic leukemia |
| 04/06/2011 | EP2303249A2 Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions |
| 04/06/2011 | EP2303237A2 Preparation method of biodegradable micro-particles containing drugs |
| 04/06/2011 | EP2303236A2 Synergistic induction of humoral and cellular immunity by combinatorial activation of toll-like receptors |
| 04/06/2011 | EP2303021A2 Compounds for the treatment of cancer |
| 04/06/2011 | EP2303018A1 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds |
| 04/06/2011 | EP2303017A1 Inhibitors of akt activity |
| 04/06/2011 | EP2091925B1 Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for production of same |
| 04/06/2011 | EP2059518B1 Salts of benzimidazolyl pyridyl ethers and formulations thereof |
| 04/06/2011 | EP1984005B1 Use of gallium(iii) complexes for the treatment of melanomas |
| 04/06/2011 | EP1848414B1 Method for treating gefitinib resistant cancer |
| 04/06/2011 | EP1838737B1 Binding proteins specific for human matriptase |
| 04/06/2011 | EP1805160B1 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 04/06/2011 | EP1711185B1 Combination of roscovitine cs-682 or its metabolite cndac |
| 04/06/2011 | EP1685832B1 Nerve regeneration promoters |
| 04/06/2011 | EP1404356B1 Method for designing cd10-activated prodrug compounds |
| 04/06/2011 | EP1370277B1 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
| 04/06/2011 | EP1328236B1 Methods of decreasing or preventing pain using spicamycin derivatives |
| 04/06/2011 | EP1303522B1 Biologically active macrolides, compositions, and uses thereof |
| 04/06/2011 | EP1303479B1 7-, 8- and 9-substituted tetracycline compounds |
| 04/06/2011 | EP1291424B1 Gasc1 gene |
| 04/06/2011 | CN1910284B Epitope/peptide recognized by HLA-A2402-restricted Ep-CAM-specific CTL and use of the same |
| 04/06/2011 | CN1905864B DNA damage repair inhibitors for treatment of cancer |
| 04/06/2011 | CN1886143B Agent and method for treating cancer comprising strontium, amino acid(s) and mineral agent(s) |
| 04/06/2011 | CN1883710B Chemical modification method of antineoplastic oligopeptide and application thereof |
| 04/06/2011 | CN1858040B 5,8-disubstituted quinazoline and its preparing method and use |
| 04/06/2011 | CN1840177B Injection liquid of thymic peptide alpha 1 and preparation method thereof |
| 04/06/2011 | CN1812980B Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
| 04/06/2011 | CN1649612B Induction method for cell differentiation |
| 04/06/2011 | CN1376146B Solid-state form of celecoxil having enhanced bioavailability |
| 04/06/2011 | CN102007147A Anti-cd27 antibody |
| 04/06/2011 | CN102007134A Copper organocomplexes, use thereof as antitumor means and for protecting healthy tissue from ionizing radiation |
| 04/06/2011 | CN102007127A Furo- and thieno [3,2-c] pyridines |
| 04/06/2011 | CN102007125A Fused heterocyclic derivatives and methods of use |
| 04/06/2011 | CN102007124A Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases |
| 04/06/2011 | CN102006891A Continuous cell programming devices |
| 04/06/2011 | CN102006886A Therapeutic use of anti-tweak receptor antibodies |
| 04/06/2011 | CN102006866A Kinase protein binding inhibitors |
| 04/06/2011 | CN102006864A Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas |
| 04/06/2011 | CN102006859A Stable elsamitrucin salt formulations |
| 04/06/2011 | CN102002513A Efficiently-mediated DC gene transfer recombinant adenovirus |
| 04/06/2011 | CN102002484A Preparation method and application of adenovirus-alphavirus hybrid virus |
| 04/06/2011 | CN102002110A Preparation method of polysaccharides from sea cucumber |
| 04/06/2011 | CN102002105A Gene, expression vector, expression method, expression cell and application of human papilloma virus (HPV) 16 E7E6 fusion protein |
| 04/06/2011 | CN102002104A Anti-VEGF monoclonal antibody and medicinal composition containing same |
| 04/06/2011 | CN102002096A Amphipathic compound using somatostatin analogue as target radical and pharmaceutics application thereof |
| 04/06/2011 | CN102002071A Ferrocenedicarboxylic acid trialkyl tin chloride coordination compound as well as preparation method and application thereof |
| 04/06/2011 | CN102002063A Dipeptide boric acid consisting of carboxylic acid and beta amino acid, and ester compound, preparation method and usage thereof |
| 04/06/2011 | CN102002051A ent-6,7-open-cycle kaurene type rubescensine A derivative with anti-tumor activity and preparation method and use thereof |
| 04/06/2011 | CN102002048A Water-soluble anionic bacteriochlorophyll derivatives and their uses |
| 04/06/2011 | CN102002044A Purine-8-ketone and thiazolopyrimidine derivatives, and preparation method and medicinal application thereof |
| 04/06/2011 | CN102002041A Phenanthroindolizidine alkaloid derivates and salt thereof as well as application of anti-cancer activity of phenanthroindolizidine alkaloid derivates and salt thereof |
| 04/06/2011 | CN102002035A Delta and epsilon crystal forms of imatinib mesylate |
| 04/06/2011 | CN102002001A 2,2'-(1,4-phenylene) di(benzimidazole-5-carboxylic acid) and preparation method thereof |
| 04/06/2011 | CN102000346A Nanometer nucleic acid guide medicine, and preparation method and application thereof |
| 04/06/2011 | CN102000345A Complex folic acid/beta-cyclodextrin composite and preparation method thereof |
| 04/06/2011 | CN102000342A Preparation method of superparamagnetism conductive nano gamma-ferric oxide/ polyaniline-dexamethasone sodium phosphate |
| 04/06/2011 | CN102000340A Targeted polymer medicament carrier and preparation method and application thereof |
| 04/06/2011 | CN102000323A Application of SJ16 protein in preparing immunosuppressive drugs |
| 04/06/2011 | CN102000322A Drug resisting against liver cancer, and preparation and application thereof |
| 04/06/2011 | CN102000303A Compound traditional Chinese medicine preparation for suppressing tumors |
| 04/06/2011 | CN102000263A Traditional Chinese medicine preparation for treating lung cancer |
| 04/06/2011 | CN102000252A Medicine for treating blood tumor and preparation method thereof |
| 04/06/2011 | CN102000248A Application of garlic in treating anal cancer |
| 04/06/2011 | CN102000215A Method for preparing total lignans of Indian stringbush root |
| 04/06/2011 | CN102000208A Method for extracting and preparing medlar leaf flavone |
| 04/06/2011 | CN102000139A Detection method for Aidi injection |
| 04/06/2011 | CN102000131A Preparation method of cancer-removing tablets |
| 04/06/2011 | CN102000120A Method for extracting medicinal active substance from suillus luteus and application |
| 04/06/2011 | CN102000117A Use of nutgall extract in preparing medicine for inhibiting cell proliferation of colon cancer |
| 04/06/2011 | CN102000112A Separation and preparation of biologically active fraction and subfraction as anticancer drug from camel urine |
| 04/06/2011 | CN102000103A Medicinal application of 2'-fluoro-4'-nitrine-nucleoside analogues or salt thereof |
| 04/06/2011 | CN102000099A Medicine for treating breast cancer and preparation method thereof |
| 04/06/2011 | CN102000097A Bunge auriculate root C21 total steroidal glycoside degradation product and antitumor effect thereof |
| 04/06/2011 | CN102000094A Ibandronic acid-containing medicinal composition and preparation process thereof |
| 04/06/2011 | CN102000091A Bufarenogin, and application of derivatives and pharmaceutically acceptable salts thereof |
| 04/06/2011 | CN102000085A Medicament for treating breast cancer and preparation method thereof |
| 04/06/2011 | CN102000080A Method for solubilizing camptothecin compound |
| 04/06/2011 | CN102000072A Anti-tumor natural medicine coupled with nitric oxide donor and medical use thereof |
| 04/06/2011 | CN102000070A Manganoporphyrin-lonidamine combined drug for treating tumor |
| 04/06/2011 | CN102000066A Inula helianthus-aquatica extract, anti-tumor medicament using same as active ingredient, preparation method and application thereof |
| 04/06/2011 | CN102000065A Anti-cancer formulation |
| 04/06/2011 | CN102000055A Antitumor medicament containing isolicoflavonol and application thereofl |
| 04/06/2011 | CN102000051A Application of 5-caffeoylquinic acid in preparing anti-tumor drugs |
| 04/06/2011 | CN102000047A Antrodia camphorata cyclonene compound for restraining growth of bone cancer cells |
| 04/06/2011 | CN102000046A Antrodia camphorata cyclohexenone compound for inhibiting growth of pancreatic cancer tumor cells |